{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:53:40Z","timestamp":1775868820717,"version":"3.50.1"},"reference-count":36,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/121558\/2016"],"award-info":[{"award-number":["SFRH\/BPD\/121558\/2016"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PD\/BD\/114034\/2015"],"award-info":[{"award-number":["PD\/BD\/114034\/2015"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PD\/BD\/135501\/2018"],"award-info":[{"award-number":["PD\/BD\/135501\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Processes"],"abstract":"<jats:p>Biopharmaceuticals are currently becoming one of the fastest growing segments of the global pharmaceutical industry, being used in practically all branches of medicine from disease treatment to prevention. Virus-like particles (VLP) hold tremendous potential as a vaccine candidate due to their anticipated immunogenicity and safety profile when compared to inactivated or live attenuated viral vaccines. Nevertheless, there are several challenges yet to be solved in the development and manufacturing of these products, which ultimately can increase time to market. Suchlike virus-based products, the development of a platform approach is often hindered due to diversity and inherent variability of physicochemical properties of the product. In the present work, a flow-through chromatographic purification strategy for hepatitis C VLP expressed using the baculovirus-insect cell expression system was developed. The impact of operational parameters, such as residence time and ionic strength were studied using scaled-down models and their influence on the purification performance was described. The flow-through strategy herein reported made use of radial-flow chromatography columns packed with an anion exchanger and was compared with a bind and elute approach using the same chromatography media. Overall, by selecting the optimal operational setpoints, we were able to achieve higher VLP recoveries in the flow-through process (66% versus 37%) with higher removal of DNA, baculovirus and host-cell protein (92%, 99% and 50% respectively).<\/jats:p>","DOI":"10.3390\/pr8010085","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T03:07:11Z","timestamp":1578539231000},"page":"85","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Flow-Through Chromatographic Strategy for Hepatitis C Virus-Like Particles Purification"],"prefix":"10.3390","volume":"8","author":[{"given":"Ricardo J. S.","family":"Silva","sequence":"first","affiliation":[{"name":"iBET, Instituto de Biologia Experimental e Tecnol\u00f3gica, Apartado 12, 2780-901 Oeiras, Portugal"}]},{"given":"Mafalda G.","family":"Moleirinho","sequence":"additional","affiliation":[{"name":"iBET, Instituto de Biologia Experimental e Tecnol\u00f3gica, Apartado 12, 2780-901 Oeiras, Portugal"},{"name":"ITQB NOVA, Instituto de Tecnologia Qu\u00edmica e Biol\u00f3gica Ant\u00f3nio Xavier, Universidade Nova de Lisboa, Av. da Rep\u00fablica, 2780-157 Oeiras, Portugal"}]},{"given":"Ana S.","family":"Moreira","sequence":"additional","affiliation":[{"name":"iBET, Instituto de Biologia Experimental e Tecnol\u00f3gica, Apartado 12, 2780-901 Oeiras, Portugal"},{"name":"ITQB NOVA, Instituto de Tecnologia Qu\u00edmica e Biol\u00f3gica Ant\u00f3nio Xavier, Universidade Nova de Lisboa, Av. da Rep\u00fablica, 2780-157 Oeiras, Portugal"}]},{"given":"Alex","family":"Xenopoulos","sequence":"additional","affiliation":[{"name":"EMD Millipore Corporation, 80 Ashby Road, Bedford, MA 01730, USA"}]},{"given":"Paula M.","family":"Alves","sequence":"additional","affiliation":[{"name":"iBET, Instituto de Biologia Experimental e Tecnol\u00f3gica, Apartado 12, 2780-901 Oeiras, Portugal"},{"name":"ITQB NOVA, Instituto de Tecnologia Qu\u00edmica e Biol\u00f3gica Ant\u00f3nio Xavier, Universidade Nova de Lisboa, Av. da Rep\u00fablica, 2780-157 Oeiras, Portugal"}]},{"given":"Manuel J. T.","family":"Carrondo","sequence":"additional","affiliation":[{"name":"iBET, Instituto de Biologia Experimental e Tecnol\u00f3gica, Apartado 12, 2780-901 Oeiras, Portugal"}]},{"given":"Cristina","family":"Peixoto","sequence":"additional","affiliation":[{"name":"iBET, Instituto de Biologia Experimental e Tecnol\u00f3gica, Apartado 12, 2780-901 Oeiras, Portugal"},{"name":"ITQB NOVA, Instituto de Tecnologia Qu\u00edmica e Biol\u00f3gica Ant\u00f3nio Xavier, Universidade Nova de Lisboa, Av. da Rep\u00fablica, 2780-157 Oeiras, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2020,1,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3389\/fmicb.2017.02163","article-title":"The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine","volume":"8","author":"Torresi","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jhep.2010.09.040","article-title":"Progress in the development of preventive and therapeutic vaccines for hepatitis C virus","volume":"54","author":"Torresi","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/biot.201400387","article-title":"Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology","volume":"10","author":"Rodrigues","year":"2015","journal-title":"Biotechnol. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12275-017-7058-3","article-title":"Exploiting virus-like particles as innovative vaccines against emerging viral infections","volume":"55","author":"Jeong","year":"2017","journal-title":"J. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1586\/erv.13.10","article-title":"Virus-like particle-based vaccines against hepatitis C virus infection","volume":"12","author":"Bellier","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Soares, H.R., Castro, R., Tom\u00e1s, H.A., Carrondo, M.J.T., Alves, P.M., and Coroadinha, A.S. (2019). Pseudotyping retrovirus like particles vaccine candidates with Hepatitis C virus envelope protein E2 requires the cellular expression of CD81. AMB Express, 9.","DOI":"10.1186\/s13568-019-0741-5"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4155\/pbp.13.55","article-title":"Emerging technologies for the integration and intensification of downstream bioprocesses","volume":"1","author":"Azevedo","year":"2013","journal-title":"Pharm. Bioprocess."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/10837459809009864","article-title":"Development of a Highly Efficient Purification Process for Recombinant Adenoviral Vectors for Oral Gene Delivery","volume":"3","author":"Croyle","year":"1998","journal-title":"Pharm. Dev. Technol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1038\/sj.gt.3302624","article-title":"Downstream processing of viral vectors and vaccines","volume":"12","author":"Morenweiser","year":"2005","journal-title":"Gene Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1016\/j.vaccine.2017.03.016","article-title":"A fast and efficient purification platform for cell-based influenza viruses by flow-through chromatography","volume":"36","author":"Tseng","year":"2018","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.chroma.2006.12.094","article-title":"Sorption processes in ion-exchange chromatography of viruses","volume":"1142","author":"Trilisky","year":"2007","journal-title":"J. Chromatogr. A"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/bit.20111","article-title":"Bioseparations","volume":"87","author":"Lightfoot","year":"2004","journal-title":"Biotechnol. Bioeng."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.jip.2011.05.004","article-title":"Large-scale production and purification of VLP-based vaccines","volume":"107","author":"Vicente","year":"2011","journal-title":"J. Invertebr. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.seppur.2019.02.040","article-title":"Efficient filtration strategies for the clarification of influenza virus-like particles derived from insect cells","volume":"218","author":"Carvalho","year":"2019","journal-title":"Sep. Purif. Technol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1800570","DOI":"10.1002\/biot.201800570","article-title":"Membrane-Based Approach for the Downstream Processing of Influenza Virus-Like Particles","volume":"14","author":"Carvalho","year":"2019","journal-title":"Biotechnol. J."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Durous, L., Rosa-Calatrava, M., and Petiot, E. (2019). Advances in Influenza Virus-Like Particles bioprocesses. Expert Rev. Vaccines.","DOI":"10.1080\/14760584.2019.1704262"},{"key":"ref_17","unstructured":"Moleirinho, M.G., Silva, R.J.S., Alves, P.M., Carrondo, M.J.T., and Peixoto, C. (2019). Current challenges in biotherapeutic particles manufacturing. Expert Opin. Biol. Ther., 1\u201315."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1016\/j.vaccine.2019.07.001","article-title":"Polymer-grafted chromatography media for the purification of enveloped virus-like particles, exemplified with HIV-1 gag VLP","volume":"37","author":"Schneider","year":"2019","journal-title":"Vaccine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1089\/hum.2005.16.1346","article-title":"Serotype Specificity of Adenovirus Purification Using Anion-Exchange Chromatography","volume":"16","author":"Konz","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2672.2010.04663.x","article-title":"Isoelectric points of viruses","volume":"109","author":"Michen","year":"2010","journal-title":"J. Appl. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chroma.2016.03.066","article-title":"Negative chromatography of hepatitis B virus-like particle: Comparative study of different adsorbent designs","volume":"1445","author":"Lee","year":"2016","journal-title":"J. Chromatogr. A"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jchromb.2006.07.064","article-title":"Evaluation of radial chromatography versus axial chromatography, practical approach","volume":"845","author":"Cabanne","year":"2007","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.chroma.2012.11.027","article-title":"Are axial and radial flow chromatography different?","volume":"1271","author":"Besselink","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/btpr.5420040306","article-title":"Scaling-Up of Affinity Chromatography by Radial-Flow Cartridges","volume":"4","author":"Huang","year":"1988","journal-title":"Biotechnol. Prog."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/gt.2009.33","article-title":"Purification of recombinant baculoviruses for gene therapy using membrane processes","volume":"16","author":"Vicente","year":"2009","journal-title":"Gene Ther."},{"key":"ref_26","unstructured":"Jagschies, G., Lindskog, E., Lacki, K., and Galliher, P. (2018). Biopharmaceutical Processing: Development, Design, and Implementation of Manufacturing Processes, Elsevier."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Johnson, C., and Frantz, S. (2013). Role of Study Director and Study Monitor in Drug Development. A Comprehensive Guide to Toxicology in Preclinical Drug Development, Academic Press.","DOI":"10.1016\/B978-0-12-387815-1.00031-9"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-61779-095-9_4","article-title":"Overview of Current Scalable Methods for Purification of Viral Vectors","volume":"737","author":"Segura","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/bit.25545","article-title":"Improved virus purification processes for vaccines and gene therapy","volume":"112","author":"Nestola","year":"2015","journal-title":"Biotechnol. Bioeng."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1021\/bp050425v","article-title":"Basic Concepts in Q Membrane Chromatography for Large-Scale Antibody Production","volume":"22","author":"Zhou","year":"2006","journal-title":"Biotechnol. Prog."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1097-4660(199806)72:2<149::AID-JCTB886>3.0.CO;2-C","article-title":"Production and quality analysis of Pr55gag particles produced in baculovirus-infected insect cells","volume":"72","author":"Cruz","year":"1998","journal-title":"J. Chem. Technol. Biotechnol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/biot.201400438","article-title":"The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors","volume":"10","author":"Felberbaum","year":"2015","journal-title":"Biotechnol. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF02931870","article-title":"Protein adsorption on Ion exchange resin: Estimation of equilibrium isotherm parameters from batch kinetic data","volume":"11","author":"Chu","year":"2006","journal-title":"Biotechnol. Bioprocess Eng."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4155\/pbp.15.29","article-title":"Improving the downstream processing of vaccine and gene therapy vectors with continuous chromatography","volume":"3","author":"Silva","year":"2015","journal-title":"Pharm. Bioprocess."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/hgtb.2012.059","article-title":"Downstream processing of lentiviral vectors: Releasing bottlenecks","volume":"23","author":"Bandeira","year":"2012","journal-title":"Hum. Gene Ther. Methods"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/bp050294y","article-title":"Screening of novel excipients for improving the stability of retroviral and adenoviral vectors","volume":"22","author":"Cruz","year":"2006","journal-title":"Biotechnol. Prog."}],"container-title":["Processes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9717\/8\/1\/85\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:29:05Z","timestamp":1760362145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9717\/8\/1\/85"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,8]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["pr8010085"],"URL":"https:\/\/doi.org\/10.3390\/pr8010085","relation":{},"ISSN":["2227-9717"],"issn-type":[{"value":"2227-9717","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,8]]}}}